tiprankstipranks
Trending News
More News >
Pyxis Oncology (PYXS)
NASDAQ:PYXS
US Market

Pyxis Oncology (PYXS) Income Statement

Compare
548 Followers

Pyxis Oncology Income Statement

Last quarter (Q3 2025), Pyxis Oncology's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Pyxis Oncology's net income was $-22.00M. See Pyxis Oncology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 16.15M$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 15.67M$ 0.00$ 0.00$ 0.00$ -444.00K
Operating Expenses
$ 105.13M$ 82.20M$ 123.48M$ 69.72M$ 12.45M
Depreciation and Amortization
$ 2.98M$ 1.93M$ 709.00K$ 647.00K$ 444.00K
EBITDA
$ -65.51M$ -80.27M$ -122.77M$ -69.07M$ -12.38M
Operating Income
$ -89.46M$ -82.20M$ -123.48M$ -69.72M$ -12.89M
Other Income/Expenses
$ 9.96M$ 8.41M$ 2.76M$ -6.26M$ 66.00K
Pretax Income
$ -79.50M$ -73.79M$ -120.72M$ -75.97M$ -12.83M
Net Income
$ -77.33M$ -73.79M$ -120.72M$ -75.97M$ -12.83M
Per Share Metrics
Basic EPS
$ -1.32$ -1.85$ -3.57$ -2.53$ -0.37
Diluted EPS
$ -1.32$ -1.85$ -3.57$ -2.53$ -0.37
Weighted Average Shares Outstanding
58.45M 39.90M 33.03M 32.22M 34.31M
Weighted Average Shares Outstanding (Diluted)
58.45M 39.90M 33.03M 32.22M 34.31M
Currency in USD

Pyxis Oncology Earnings and Revenue History